BeStock  
Markets › Compare › TARS vs CRSP

TARS vs CRSP

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TARS · Tarsus Pharmaceuticals$73.01 ▼ 6.00%
CRSP · CRISPR Therapeutics$39.10 ▲ 0.44%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

658095109124Nov 24, '25May 26, '26Nov 20, '26
  • TARS -11.1%
  • CRSP -23.7%

Head to head

MetricTARSCRSP
Price$73.01$39.10
Change today▼ 6.00%▲ 0.44%
Market cap$3.60B$3.79B
Return, 3 months+0.3%-31.5%
Return, year to date-10.8%-25.4%
Return, 1 year-8.3%-22.2%
P/E (TTM)––
P/B34.62.3
P/E percentile vs own 5y90th53rd
Dividend yield––
Revenue growth (YoY, latest qtr)+63.9%+1,325.1%
Net profit growth (YoY)-5,210.6%-4.7%
Gross margin93.2%-676.9%
Operating margin-102.3%-2,221.7%
Net margin-102.9%-1,955.7%
Return on equity-319.8%-25.6%
Analyst target vs. price+44.6%+89.9%
Analyst buy share100%67%
RSI (14)4828
30-day volatility48.8%56.0%
Max drawdown, 1 year-32.0%-37.1%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CRSP is the largest of the group by market value.
  • TARS has returned the most over the past year.
  • CRSP is growing revenue fastest.
  • TARS keeps the most profit per dollar of sales.
  • TARS has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top